跳至主要内容
临床试验/JPRN-UMIN000006256
JPRN-UMIN000006256已完成未知

Evaluation of clinical efficacy of transdermal Tulobuterol to the small airway dysfunction in patient with COPD. - Evaluation of IOS of transdermal Tulobuterol.

Kanazawa Medical University0 个研究点目标入组 10 人开始时间: 2011年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patient of the symptom that bronchial asthma is main. 2)Patient who takes oral corticosteroid. 3)Patient who uses home oxygen therapy. 4)Patients with a history of hypersensitivity to Tulobuterol. 5)Patient who was considered ineligible to use transdermal Tulobuterol in a patient having skin diseases such as atopic dermatitis. 6)Patient who was considered ineligible to use bata2 agonist in a patient complicated with hyperthyroidism, hypertension, heart disease and diabetes mellitus. 7)Woman who are pregnant or breast feeding, and woman of childbearing potential. 8)Patient who was considered ineligible by the investigators.

研究者

相似试验

Evaluation of clinical efficacy of transdermal... | 临床试验